AssetMark Inc’s LeMaitre Vascular LMAT Stock Holding History

AssetMark Inc’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.6K	Hold	110	–	–	﹤0.01%	2427
2026 Q1	$12K	Buy	110 +7	+7%	+$667	﹤0.01%	2249
2025 Q4	$8.35K	Buy	103 +9	+10%	+$775	﹤0.01%	2282
2025 Q3	$8.23K	Buy	94 +52	+124%	+$4.64K	﹤0.01%	2179
2025 Q2	$3.49K	Buy	+42	New	+$3.51K	﹤0.01%	2248
2018 Q1	–	Sell	-4	Closed	–	–	1721
2017 Q4	$0	Buy	+4	New	+$137	﹤0.01%	2008

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AssetMark Inc's LMAT Position: Q2 2026 in Review

AssetMark Inc held its LeMaitre Vascular (LMAT) position steady in Q2 2026 at 110 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2427.

AssetMark Inc first reported a position in LMAT in Q4 2017 and has held it in 6 quarters since. The position peaked at $12K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

AssetMark Inc held 110 shares of LeMaitre Vascular worth $10.6K as of Q2 2026.
AssetMark Inc left its LeMaitre Vascular share count unchanged in Q2 2026.
LeMaitre Vascular made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #2427 holding.
AssetMark Inc first reported a position in LeMaitre Vascular in Q4 2017 and has held it in 6 quarters since.
AssetMark Inc's LeMaitre Vascular position peaked at $12K in Q1 2026.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.